Results 161 to 170 of about 82,056 (314)

Interventional oncology in children: Where are we now?

Journal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel, Fernando Gómez Muñoz   +1 more
wiley   +1 more source

Transplantation and other aspects of surgery of the liver [PDF]

, 1984
Iwatsuki, S, Shaw, BW, Starzl, TE, Van Thiel, DH   +3 more
core  

Risks and benefits of weaning immunosuppression in liver transplant recipients: Long-term follow-up [PDF]

, 1997
Flynn, B, Fung, JJ, Marino, I, Mazariegos, GV, Reyes, J, Starzl, IE   +5 more
core   +1 more source

Imaging of Abdominal Complications in Children With Acute Lymphoblastic Leukaemia

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy and remains one of the most common causes of cancer‐related death in children and adolescents. Five‐year overall survival rates now exceed 90% with current multidrug chemotherapeutic regimens. This improvement, coupled with the toxicity of chemotherapy, has led to the
Luke R. Holmes, Rishi S. Kotecha, Derek J. Roebuck   +2 more
wiley   +1 more source

Pediatric Cholestasis: A Practical Approach to Histological Diagnosis. [PDF]

Diagnostics (Basel)
Arienzo F, Vallese S, Giovannoni I, Pietrobattista A, Spada M, Alaggio R, Francalanci P.   +6 more
europepmc   +1 more source

Index to Predict Waiting Times for Pediatric Liver Transplantation. [PDF]

Pediatr Transplant
Using national OPTN/UNOS data, this study identifies clinical and transplant center factors that influence pediatric liver transplant wait times and introduces a points‐based model to estimate the likelihood of transplantation within 1 year. The model highlights candidates at risk for prolonged waiting and supports earlier consideration of alternative ...
Shin E, Montgomery A, Crawford M, Wortham G, Robinson C, Goss J, Galván NTN, Rana A.   +7 more
europepmc   +2 more sources

Comparative Outcomes of Reinforced Tension‐Line Sutures Versus Standard Closure Techniques in Patients Undergoing Laparotomy: A Systematic Review and Meta‐Analysis

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background The reinforced tension‐line suture (RTLS) technique distributes mechanical stress more evenly than traditional closure when closing a laparotomy wound, potentially reducing incisional hernia (IH) risk. We aimed to compare outcomes of RTLS versus standard closure techniques in patients undergoing laparotomy. Methods Systematic search
Rama H. G. Mikhail, Shahin Hajibandeh, Shahab Hajibandeh, Marty Smith, Ee Jun Ban, Rodney Jacobs, Siobhan C. McKay   +6 more
wiley   +1 more source

Late-Stage Diagnosis of Biliary Atresia in Rural America. [PDF]

Cureus
Khan S, Barsamian J, Dunbar CW, Litvinchuk T.   +3 more
europepmc   +1 more source

Plasma Adsorption Perfusion (BR‐350) Versus Open Albumin Dialysis (OPAL) for Hyperbilirubinemia in Hepatic Failure in Cirrhotic Patients

Artificial Organs, EarlyView.
The therapy with PAP using BR‐350 resulted in a significant decrease of bilirubin concentrations. The median relative reduction of bilirubin was comparable between PAP and OPAL (47% vs. 40%, p = 0.29). The crossover comparison between the single session of PAP using BR‐350 and OPAL revealed similar relative reduction rates of bilirubin.
Justa Friebus‐Kardash, Alica Ochs, Amina Louzi, Andreas Kribben, Bartosz Tyczynski, Jassin Rashidi‐Alavijeh, Andreas Schütte, Hartmut H. Schmidt, Amos Zeller   +8 more
wiley   +1 more source

The Alpha‐1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD

Alimentary Pharmacology &Therapeutics, EarlyView.
Alpha‐1 antitrypsin deficiency is a genetic disease that affects the lungs and the liver. The role of the heterozygous genetic defect in the development of liver cancer in patients with cirrhosis is unclear. Our study found that carrying the Pi*MZ genotype increases the risk of developing liver cancer.
Lorenz Balcar, Georg Semmler, Bernhard Scheiner, Rafael Paternostro, Benedikt Simbrunner, Tina Jasmin Haunold, Mathias Jachs, Lukas Hartl, Benedikt Silvester Hofer, Nina Dominik, Michael Schwarz, Georg Kramer, Christian Sebesta, Paul Thöne, Matthias Pinter, Michael Trauner, Thomas Reiberger, Albert Friedrich Stättermayer, Mattias Mandorfer   +18 more
wiley   +1 more source